E X P E R T
(^) P
A
N
E
L
(^)
N
O
W
(^) C
O
N
F
IR
M
E
D
Subscriber^
Event
There is a lot of excitement about the potential role
psychedelics could play in treating mental health conditions,
including depression, PTSD and addiction. Interesting
results in a growing number of clinical trials and in rigorous
academic research are bringing this controversial topic to
the fore, but questions remain.
What role can and should psychedelics play in the
treatment of mental health conditions? Are they safe? How
has the ban on these drugs affected research? How and
why might psychedelics have such an effect? And could we
replicate the effects of psychedelics without the trip?
Join our panel of experts as they discuss these
questions and more in our second subscriber-only event
of 2022 – with the agenda set by you, the audience.
To register and submit your questions visit
newscientist.com/juneevent2
You will need your 8 digit subscriber number which can
be found on our customer service and event emails.
Chen Ly
New Scientist social
media manager
Daniel Cossins
New Scientist deputy
head of features
Grace Wade
New Scientist US-based
health reporter
Ros McAlpine
PhD researcher at UCL Institute
of Mental Health Science
PANEL INCLUDES:
ONLINE EVENT
PSYCHEDELICS AND
MENTAL HEALTH
YOUR QUESTIONS ANSWERED
28 June 6 -7pm BST and on-demand
Scan me to register